Dopamine D3 receptors regulate reconsolidation of cocaine memory

Neuroscience

Volumn 241, Issue , 2013, Pages 32-40

  Yan, Y ^a   Kong, H ^a   Wu, E J ^b   Newman, A H ^c   Xu, M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Antagonist PG01037; Cocaine; Dopamine D3 receptor; Mutant mice; Reconsolidation; Reward learning

Indexed keywords

COCAINE; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; INFORMATION RETRIEVAL; MALE; MEMORY CONSOLIDATION; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; WILD TYPE; WITHDRAWAL SYNDROME;

ANIMALS; COCAINE-RELATED DISORDERS; CONDITIONING, OPERANT; CUES; EXTINCTION, PSYCHOLOGICAL; FEMALE; MALE; MEMORY; MICE; MICE, KNOCKOUT; RECEPTORS, DOPAMINE D3; REWARD;

EID: 84876316924     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.03.005     Document Type: Article

References (67)

1. Achat-Mendes C., Grundt P., Cao J., Platt D.M., Newman A.H., Spealman R.D. Dopamine D3 and D2 receptor mechanisms in the abuse-related behavioral effects of cocaine: studies with preferential antagonists in squirrel monkeys. J Pharmacol Exp Ther 2010, 334:556-565.
2. Alberini C.M. The role of reconsolidation and the dynamic process of long-term memory formation and storage. Front Behav Neurosci 2011, 5:12-21.
3. Beaulieu J.M., Gainetdinov R.R. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 2011, 63:182-217.
4. Boileau I., Payer D., Houle S., Behzadi A., Rusjan P.M., Tong J., Wilkins D., Selby P., George T.P., Zack M., Furukawa Y., McCluskey T., Wilson A.A., Kish S.J. Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study. J Neurosci 2012, 32:1353-1359.
5. 3 receptors attenuates cocaine-seeking behaviour in the rat. Int J Neuropsychopharm 2007, 10:167-181.
6. Chen L.P., Xu M. Dopamine D1 and D3 receptors are differentially involved in cue-elicited cocaine seeking. J Neurochem 2010, 114:530-541.
7. Choi J.K., Mandeville J.B., Chen Y.I., Grundt P., Sarkar S.K., Newman A.H., Jenkins B.G. Imaging brain regional and cortical laminar effects of selective D3 agonists and antagonists. Psychopharmacology (Berl) 2010, 212:59-72.
8. Collins G.T., Witkin J.M., Newman A.H., Svensson K.A., Grundt P., Cao J., Woods J.H. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior. J Pharmacol Exp Ther 2005, 314:310-319.
9. Collins G.T., Newman A.H., Grundt P., Rice K.C., Husbands S.M., Chauvignac C., Chen J., Wang S., Woods J.H. Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists. Psychopharmacology (Berl) 2007, 193:159-170.
10. Dackis C., O'Brien C. Neurobiology of addiction: treatment and public policy ramifications. Nat Neurosci 2005, 8:1431-1436.
11. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 1988, 85:5274-5278.
12. Di Ciano P. Drug seeking under a second-order schedule of reinforcement depends on dopamine D3 receptors in the basolateral amygdala. Behav Neurosci 2008, 122:129-139.
13. Di Ciano P., Underwood R.J., Hagan J.J., Everitt B.J. Attenuation of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-A. Neuropsychopharmacology 2003, 28:329-338.
14. Everitt B.J., Robbins T.W. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 2005, 8:1481-1488.
15. Grundt P., Carlson E.E., Cao J., Bennett C.J., McElveen E., Taylor M., Luedtke R.R., Newman A.H. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor. J Med Chem 2005, 48:839-848.
16. Grundt P., Prevatt K.M., Cao J., Taylor M., Floresca C.Z., Choi J.K., Jenkins B.G., Luedtke R.R., Newman A.H. Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents. J Med Chem 2007, 50:4135-4146.
17. Heidbreder C.A., Newman A.H. Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders. Ann N Y Acad Sci 2010, 1187:4-34.
18. Heidbreder C.A., Gardner E.L., Xi Z.X., Thanos P.K., Mugnaini M., Hagan J.J., Ashby C.R. The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence. Brain Res Brain Res Rev 2005, 49:77-105.
19. Higley A.E., Spiller K., Grundt P., Newman A.H., Kiefer S.W., Xi Z.X., Gardner E.L. PG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in rats. J Psychopharmacol 2011, 25:263-273.
20. Hyman S.E., Malenka R.C., Nestler E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 2006, 29:565-598.
21. Ito R., Dalley J.W., Howes S.R., Robbins T.W., Everitt B.J. Dissociation in conditioned dopamine release in the nucleus accumbens core and shell in response to cocaine cues and during cocaine-seeking behavior in rats. J Neurosci 2000, 20:7489-7495.
22. Kalivas P.W., Volkow N.D. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 2005, 162:1403-1413.
23. Karasinska J.M., George S.R., Cheng R., O'Dowd B.F. Deletion of dopamine D1 and D3 receptors differentially affects spontaneous behaviour and cocaine-induced locomotor activity, reward and CREB phosphorylation. Eur J Neurosci 2005, 22:1741-1750.
24. Kong H., Kuang W., Li S., Xu M. Activation of dopamine D3 receptors inhibits reward-related learning induced by cocaine. Neuroscience 2011, 176:152-161.
25. Kumar R., Riddle L., Griffin S.A., Grundt P., Newman A.H., Luedtke R.R. Evaluation of the D3 dopamine receptor selective antagonist PG01037 on l-dopa-dependent abnormal involuntary movements in rats. Neuropharmacology 2009, 56:944-955.
26. Lee J.L., Di Ciano P., Thomas K.L., Everitt B.J. Disrupting reconsolidation of drug memories reduces cocaine-seeking behavior. Neuron 2005, 47:795-801.
27. Lee J.L., Milton A.L., Everitt B.J. Cue-induced cocaine seeking and relapse are reduced by disruption of drug memory reconsolidation. J Neurosci 2006, 26:5881-5887.
28. Lee J.L., Milton A.L., Everitt B.J. Reconsolidation and extinction of conditioned fear: inhibition and potentiation. J Neurosci 2006, 26:10051-10056.
29. Lüscher C., Malenka R.C. Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron 2011, 69:650-663.
30. Martelle J.L., Claytor R., Ross J.T., Reboussin B.A., Newman A.H., Nader M.A. Effects of two novel D3-selective compounds, NGB 2904 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxamide] and CJB 090 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide], on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther 2007, 321:573-582.
31. Micheli F., Heidbreder C. Selective dopamine D3 receptor antagonists 1997-2007: a decade of progress. Expert Opin Ther Pat 2008, 18:821-840.
32. Miller C.A., Marshall J.F. Molecular substrates for retrieval and reconsolidation of cocaine-associated contextual memory. Neuron 2005, 47:873-884.
33. Miller C.A., Sweatt J.D. Amnesia or retrieval deficit? Implications of a molecular approach to the question of reconsolidation. Learn Mem 2006, 5:498-505.
34. Milton A.L., Everitt B.J. The persistence of maladaptive memory: addiction, drug memories and anti-relapse treatments. Neurosci Biobehav Rev 2012, 36:1119-1139.
35. Nader K., Schafe G.E., Le Doux J.E. Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval. Nature 2000, 406:722-726.
36. Neisewander J.L., Fuchs R.A., Tran-Nguyen L.T., Weber S.M., Coffey G.P., Joyce J.N. Increases in dopamine D3 receptor binding in rats receiving a cocaine challenge at various time points after cocaine self-administration: implications for cocaine-seeking behavior. Neuropsychopharmacology 2004, 29:1479-1487.
37. Nestler E.J. Is there a common molecular pathway for addiction?. Nat. Neurosci. 2005, 8:1445-1449.
38. Neve K.A., Seamans J.K., Trantham-Davidson H. Dopamine receptor signaling. J Recept Signal Transduct Res 2004, 24:165-205.
39. Orio L., Wee S., Newman A.H., Pulvirenti L., Koob G.F. The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access. Addict Biol 2010, 15:312-323.
40. Otis J.M., Dashew K.B., Mueller D. Neurobiological dissociation of retrieval and reconsolidation of cocaine-associated memory. J Neurosci 2013, 33:1271-1281.
41. Parsons L.H., Caine S.B., Sokoloff P., Schwartz J.C., Koob G.F., Weiss F. Neurochemical evidence that postsynaptic nucleus accumbens D3 receptor stimulation enhances cocaine reinforcement. J Neurochem 1996, 67:1078-1089.
42. Pedreira M.E., Maldonado H. Protein synthesis subserves reconsolidation or extinction depending on reminder duration. Neuron 2003, 38:863-869.
43. Peng X.Q., Ashby C.R., Spiller K., Li X., Li J., Thomasson N., Millan M.J., Mocaër E., Muńoz C., Gardner E.L., Xi Z.X. The preferential dopamine D3 receptor antagonist S33138 inhibits cocaine reward and cocaine-triggered relapse to drug-seeking behavior in rats. Neuropharmacology 2009, 56:752-760.
44. Pilla M., Perachon S., Sautel F., Garrido F., Mann A., Wermuth C.G., Schwartz J.C., Everitt B.J., Sokoloff P. Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature 1999, 400:371-375.
45. Sanchez H., Quinn J.J., Torregrossa M.M., Taylor J.R. Reconsolidation of a cocaine-associated stimulus requires amygdalar protein kinase A. J Neurosci 2010, 30:4401-4407.
46. Schultz W. Dopamine signals for reward value and risk: basic and recent data. Behav Brain Funct 2010, 6:24.
47. Song R., Yang R.F., Wu N., Su R.B., Li J., Peng X.Q., Li X., Gaál J., Xi Z.X., Gardner E.L. YQA14: a novel dopamine D(3) receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D(3) receptor-knockout mice. Addict Biol 2012, 17:259-273.
48. Song R., Zhang H.Y., Li X., Bi G.H., Gardner E.L., Xi Z.X. Increased vulnerability to cocaine in mice lacking dopamine D3 receptors. Proc Natl Acad Sci U S A 2012, 109:17675-17680.
49. Sorg B.A. Reconsolidation of drug memories. Neurosci Biobehav Rev 2012, 36:1400-1417.
50. Spanagel R., Vengeliene V. New pharmacological treatment strategies for relapse prevention. Curr Top Behav Neurosci 2013, 13:583-609.
51. Staley J.K., Mash D.C. Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities. J Neurosci 1996, 16:6100-6106.
52. Stuber G.D., Wightman R.M., Carelli R.M. Extinction of cocaine self-administration reveals functionally and temporally distinct dopaminergic signals in the nucleus accumbens. Neuron 2005, 46:661-669.
53. Suzuki A., Josselyn S.A., Frankland P.W., Masushige S., Silva A.J., Kida S. Memory reconsolidation and extinction have distinct temporal and biochemical signatures. J Neurosci 2004, 24:4787-4795.
54. Taylor J.R., Olausson P., Quinn J.J., Torregrossa M.M. Targeting extinction and reconsolidation mechanisms to combat the impact of drug cues on addiction. Neuropharmacology 2009, 56:186-195.
55. Théberge F.R., Milton A.L., Belin D., Lee J.L., Everitt B.J. The basolateral amygdala and nucleus accumbens core mediate dissociable aspects of drug memory reconsolidation. Learn Mem 2010, 17:444-453.
56. Thiel K.J., Wenzel J.M., Pentkowski N.S., Hobbs R.J., Alleweireldt A.T., Neisewander J.L. Stimulation of dopamine D2/D3 but not D1 receptors in the central amygdala decreases cocaine-seeking behavior. Behav Brain Res 2010, 214:386-394.
57. Tronson N.C., Taylor J.R. Molecular mechanisms of memory reconsolidation. Nat Rev Neurosci 2007, 8:262-275.
58. Valjent E., Corbillé A.G., Bertran-Gonzalez J., Hervé D., Girault J.A. Inhibition of ERK pathway or protein synthesis during reexposure to drugs of abuse erases previously learned place preference. Proc Natl Acad Sci U S A 2006, 103:2932-2937.
59. Volkow N.D., Fowler J.S., Wang G.J., Baler R., Telang F. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 2009, 56:3-8.
60. Vorel S.R., Ashby C.R., Paul M., Liu X., Hayes R., Hagan J.J., Middlemiss D.N., Stemp G., Gardner E.L. Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J Neurosci 2002, 22:9595-9603.
61. Wise R.A. Dopamine and reward: the anhedonia hypothesis 30 years on. Neurotox Res 2008, 14:169-183.
62. Xi Z.X., Gilbert J., Campos A.C., Kline N., Ashby C.R., Hagan J.J., Heidbreder C.A., Gardner E.L. Blockade of mesolimbic dopamine D3 receptors inhibits stress-induced reinstatement of cocaine-seeking in rats. Psychopharmacology 2004, 176:57-65.
63. 3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats. Eur J Neurosci 2005, 21:3427-3438.
64. Xi Z.X., Newman A.H., Gilbert J.G., Pak A.C., Peng X.Q., Ashby C.R., Gitanjn L. The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats. Neuropsychopharmacology 2006, 31:1393-1405.
65. Xu M., Koeltzow T.E., Tirado G., Moratalla R., Cooper D.C., Hu X.T., White N.M., Graybiel A.M., White F.J., Tonegawa S. Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors. Neuron 1997, 19:837-848.
66. Xue Y.X., Luo Y.X., Wu P., Shi H.S., Xue L.F., Chen C., Zhu W.L., Ding Z.B., Bao Y.P., Shi J., Epstein D.H., Shaham Y., Lu L. A memory retrieval-extinction procedure to prevent drug craving and relapse. Science 2012, 336:241-245.
67. Zhang L., Lou D., Jiao H., Zhang D., Wang X., Ying X., Zhang J., Xu M. Cocaine-induced intracellular signaling and gene expression are oppositely regulated by the dopamine D1 and D3 receptors. J Neurosci 2004, 24:3344-3354.